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We describe a 49-year-old woman with atrial tachycardia (AT) and arrhythmogenic right ventricular
cardiomyopathy/dysplasia. Cardiac magnetic resonance images showed a markedly dilated right atrium
and right ventricle. Electroanatomical mapping showed that the AT originated from the right atrial
appendage.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Arrhythmogenic right ventricular cardiomyopathy/dysplasia
(ARVC/D) is a myocardial disease that primarily affects the right
ventricle (RV) and causes replacement of the myocardium with
fatty and ﬁbrous tissue. The predominant presenting symptoms –
palpitations, syncope, or uncommonly, sudden cardiac death –
result from ventricular tachyarrhythmias. This report describes a
case of atrial tachycardia originating from the right atrium (RA) in a
patient with ARVC/D.2. Case report
A 49-year-old woman was admitted to our hospital because of
palpitations. She had no family history of cardiac arrhythmias or
sudden cardiac death. A cardioverter-deﬁbrillator had been
implanted 7 years earlier because of nonsustained ventricular
tachycardia associated with ARVC/D. This case fulﬁlls the 2 major
criteria of ARVC/D [1]: (a) global or regional dysfunction and
structural alterations detected by magnetic resonance imaging
(MRI) (regional RV akinesia, RV contraction, or RV ejection fraction
r40%), and (b) arrhythmias (nonsustained ventricular tachycardia
of left bundle-branch morphology with a superior axis). The
patient’s chest radiograph showed an increased cardiothoracicrt Rhythm Society. Published by E
: þ81 3 3972 1098.
tanabe).ratio of 59% without pulmonary congestion. A 12-lead electrocar-
diogram (ECG) showed tiny P waves preceded by narrow QRS
complexes at a cycle length of 300 ms with variable atrioventri-
cular conduction (Fig. 1A). The signal-averaged ECG showed
positive late potentials. Transthoracic echocardiography showed a
dilated RA and RV and a left ventricular end-diastolic diameter of
52 mm with an LV ejection fraction (EF) of 35%. MRI angiography
showed an enlarged RV cavity with an RVEF of 6% (Fig. 2). A cardiac
biopsy of the RV endocardium showed ﬁbrofatty replacement of
the myocardium. During the electrophysiological study, narrow
QRS tachycardia was noted. The tachycardia was sustained,
although transient termination was observed by pacing from the
high RA. A standard mapping and ablation catheter with a 4-mm
tip (Navistar; Biosense Webster, Diamond Bar, CA, USA) was
introduced into the RA from the right femoral vein. Activation
mapping, guided by a CARTO XP system (Biosense Webster),
showed that the earliest atrial endocardial activation site of the
narrow QRS tachycardia (36 ms before the onset of the P wave)
was located at the oriﬁce of the RA appendage (RAA) (Fig. 3A) with
a cycle length (CL) of 365 ms (AT1). The patient was therefore
diagnosed with atrial tachycardia (AT) originating from the RAA.
Radiofrequency ablation (RFA) (55 1C, 25 W, 30 s per cycle) was
delivered, and after the fourth application to the same site, the AT–
CL changed to 252 ms (AT2). Activation mapping of AT2 showed
that the earliest endocardial activation (42 ms before the P wave)
was localized to the tricuspid annulus (Fig. 3B). RFA at that site
transiently terminated the AT. Atrial burst pacing induced a
different AT (AT3; CL¼430 ms), for which activation mapping
showed that the earliest endocardial activation (46 ms before thelsevier B.V. All rights reserved.
Fig. 1. Twelve-lead electrocardiograms obtained during atrial tachycardia (A) and after the ablation (B) a 12-lead electrocardiogram shows a tiny P wave preceded by a
narrow QRS rhythm at a cycle length of 300 ms (A). Baseline rhythm during atrial pacing at a cycle length of 1000 ms (B).
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Fig. 2. Magnetic resonance imaging scan shows right atrial and ventricular
dilatation.
H. Mano et al. / Journal of Arrhythmia 29 (2013) 238–241 239P wave) was at the base of the RAA (Fig. 3C). RFA at that site
changed the AT–CL to 360 ms (AT4). The earliest endocardial
activation of AT4 (54 ms before the P wave) was located adjacent
to AT1, and RFA at that site transiently terminated AT4. The P-wave
morphology did not differ among each AT (Fig. 3A–C). In the
voltage map during sinus rhythm, a low voltage area was widely
observed throughout the RA, except in the RA appendage (Fig. 4).
Thereafter, AT was not induced further by atrial extrastimulation
or burst atrial pacing. The patient has been free of any atrial or
ventricular tachyarrhythmias for 8 months.3. Discussion
In this study, AT originated in the oriﬁce of the RAA in a patient
with ARVC/D. The origins of these ATs were quite close, which is
supported by similar P-wave morphology of each AT. The ATs
could be ablated by multiple endocardial RF applications. In this
case, the exact mechanism underlying the ATs was unclear
because of the failure of detailed electrophysiologic testing.However, the activations of each AT spread from a single earliest
point of activation, and each AT activation time did not cover
490% of the tachycardia cycle length. The termination by pacing
and these activation features suggest that the mechanism of AT is
micro-reentry or triggered activity. To the best of our knowledge,
there have been no reports of AT combined with ARVC/D, and
only a few reports have described atrial involvement in ARVC/D.
In a single case, right atrial biopsies veriﬁed the presence of
ﬁbrotic replacement of the atrial myocardium in a patient with
ARVC/D, sick sinus syndrome, and an atrioventricular conduction
disturbance [2]. A previous report showed that patients with
ARVC/D had not only prolonged interatrial conduction expressed
as a longer P-wave duration but also signiﬁcant abnormalities in
the P-wave morphology [3]. Atrial involvement in ARVC/D was
also noted in several animal models of the disease, that is, the loss
of the atrial myocardium and the presence of bilateral, focal,
ﬁbrofatty atrial lesions in up to one-third of affected boxer dogs
and cats [4,5]. Takemura et al. [6] found that the RA was
electrically silent with no capture during electrical stimulation
at all sites, except for small areas in the lower RA in a patient with
ARVC/D. In fact, this patient had an extensive low voltage area
throughout the RA, and the P-wave duration during atrial pacing
was substantially prolonged after ablation (Fig. 1B). Furthermore,
the AT in our patient originated from the low voltage zone (LVZ)
or the border zone adjacent to the LVZ (Fig. 4). The LVZ contained
low-amplitude and fractionated electrograms (pink dots in Fig. 3),
suggesting slowed or anisotropic conduction through the diseased
RA. These anatomic changes could be a potential source for the
development of AT and may be related to the ﬁbrotic replacement
of the atrial myocardium in a patient with ARVC/D. The occur-
rence of AT in patients with ARVC is rare; however, care is
warranted because AT may cause inappropriate ICD discharges
in patients with ARVC/D.Disclosures and funding sources
None.
Fig. 3. Activation maps of the right atrium in the left anterior oblique (LAO) and in the cranial LAO. The earliest activation site (red) of atrial tachycardia (AT1) is located at
the oriﬁce of the right appendage (A), the tricuspid annulus for AT2 (B), the base of the RAA for AT3 (C), and the site adjacent to the AT1 for AT4 (D). The local intracardiac
electrograms at each successful ablation site are shown in the right panels. The red dots represent the points of ablation. The pink dots represent the points of fragment
potential. The blue dots represent the points of double potential.
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Fig. 4. Voltage map of the right atrium in the left anterior oblique (LAO) and in the
cranial LAO. Red indicates areas of amplitude¼0.1 mV; purple, amplitude
41.00 mV.
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